Adela Cañete Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Did we improve results in infants with MYCN Amplified Neuroblastoma? Comparison of treatment strategy and outcomes in INES 99.4 and HR-NBL1/ SIOPEN. A SIOPEN Study   — Parallel 10 High Risk Neuroblastoma